packageTalazoparib

talazoparib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Talazoparib is a PARP inhibitor anticancer drug used to treat breast cancer. It is approved and authorised in the European Union for breast cancer, though it remains a specialised oncology medicine rather than a widely used drug.

Summary written by glm-5.3-flash from Wikidata Q25100990 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:talazoparib
ATC codes:L01XK04
DrugBank:DB11760
PubChem CID:44819241
Wikidata:Q25100990
formula:C19H14F2N6O
molar mass:380.359 g/mol (knowledgebase (DrugBank calculated))
logP:2.3 (Drugs.Common 25.09, not verified)

Metabolites

NDesmethylEnzalutamideN-desmethyl enzalutamide450.41 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
NDesmethylEnzalutamidemetabolite: N-desmethyl enzalutamide